Elisabetta Bravini

Elisabetta Bravini

Auto-generated profile, based on publicly available information

Elisabetta Bravini

Rehability Bellinzona Bellinzona Switzerland

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Journal of Orthopaedic & Sports Physical Therapy
Verified
Journal Article
Closed access
FFFranco Franchignoni
Franco Franchignoni
SVStefano Vercelli
Stefano Vercelli
AGAndrea Giordano
Andrea Giordano
FSFrancesco Sartorio
Francesco Sartorio
EBElisabetta Bravini
Elisabetta Bravini
GFGiorgio Ferriero
Giorgio Ferriero
Study Design: Prospective, single-group observational design. Objectives: To determine the minimal clinically important difference (MCID) for the Disabilities of the Arm, Shoulder and Hand (DASH) outcome measure and its shortened version (QuickDASH) in patients with upper-limb musculoskeletal disorders, using a triangulation of distribution- and anchor-based approaches. Background: Meaningful threshold change values of outcome tools are crucial for the clinical decision-making process. Methods: The DASH and QuickDASH were administered to 255 patients (mean ± SD age, 49 ± 15 years; 156 women) before and after a physical therapy program. The external anchor administered after the program was a 7-point global rating of change scale. Results: The test-retest reliability of the DASH and QuickDASH was high (intraclass correlation coefficient model 2,1 = 0.93 and 0.91, respectively; n = 30). The minimum detectable change at the 90% confidence level was 10.81 points for the DASH and 12.85 points for the QuickDASH. After triangulation of these results with those of the mean-change approach and receiver-operating-characteristic-curve analysis, the following MCID values were selected: 10.83 points for the DASH (sensitivity, 82%; specificity, 74%) and 15.91 points for the QuickDASH (sensitivity, 79%; specificity, 75%). After treatment, the MCID threshold was reached/surpassed by 61% of subjects using the DASH and 57% using the QuickDASH. Conclusion: The MCID values from this study for the DASH (10.83 points) and the QuickDASH (15.91 points) could represent the lower boundary for a range of MCID values (reasonably useful for different populations and contextual characteristics). The upper boundary may be represented by the 15 points for the DASH and 20 points for the QuickDASH proposed by the DASH website. J Orthop Sports Phys Ther 2014;44(1):30–39. Epub 30 October 2013. doi:10.2519/jospt.2014.4893

4 March 2024 in Physical Therapy
Verified
Journal Article
Open access
PDF file
LGLorenzo Galardini
Lorenzo Galardini
ACAndrea Coppari
Andrea Coppari
LPLeonardo Pellicciari
Leonardo Pellicciari
AUAlessandro Ugolini
Alessandro Ugolini
DPDaniele Piscitelli
Daniele Piscitelli
SVStefano Vercelli
Stefano Vercelli
The objective of this study was to perform a meta-analysis of the minimal clinically important difference (MCID) of the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire and its shortened version (ie, the QuickDASH). MEDLINE, EMBASE, CINAHL, PsycINFO, Web of Science, Cochrane Library, and Scopus were searched up to July 2022. Studies on people with upper limb musculoskeletal disorders that calculated the MCID by anchor-based methods were included. Descriptive and quantitative synthesis was used for the MCID and the minimal detectable change with 90% confidence (MDC90). Fixed-effects models and random-effect models were used for the meta-analysis. I2 statistics was computed to assess heterogeneity. The methodological quality of studies was assessed with the Consensus-Based Standards for the Selection of Health Measurement Instruments checklist for measurement error and an adaptation of the checklist for the MCID proposed by Bohannon & Glenney. Twelve studies (1677 patients) were included, producing 17 MCID estimates ranging from 8.3 to 18.0 DASH points and 8.0 to 18.1 QuickDASH points. The pooled MCIDs were 11.00 DASH points (95% CI = 8.59 to 13.41; I2 = 0%) and 11.97 QuickDASH points (95% CI = 9.60 to 14.33; I2 = 0%). The pooled MDC90s were 9.04 DASH points (95% CI = 6.46 to 11.62; I2 = 0%) and 9.03 QuickDASH points (95% CI = 6.36 to 11.71; I2 = 18%). Great heterogeneity was identified among the primary studies along with important methodological problems in the calculation of the MCID. Reasonable MCID ranges of 12 to 14 DASH points and 12 to 15 QuickDASH points were established. The lower boundaries represent the first available measure above the pooled MDC90, and the upper limits represent the upper 95% CI of the pooled MCID. Reasonable ranges for the MCID of 12 to 14 DASH points and 12 to 15 QuickDASH points were proposed. The lower boundaries represent the first available measure above the pooled MDC90, and the upper limits represent the upper 95% CI of the pooled MCID. Information regarding the interpretability of the 2 questionnaires was derived from very different methodologies, making it difficult to identify reliable thresholds. Now clinicians and researchers can rely on more credible data. The MCID proposed should be used to assess people with musculoskeletal disorders. Heterogeneity was found related particularly to the anchor levels used in the primary studies. To promote comparability of MCID values, shared rules defining the most appropriate types of anchoring will be needed in the near future.

1 January 2013 in Journal of Hand Therapy
Verified
Journal Article
Closed access
FSFrancesco Sartorio
Francesco Sartorio
EBElisabetta Bravini
Elisabetta Bravini
SVStefano Vercelli
Stefano Vercelli
GFGiorgio Ferriero
Giorgio Ferriero
GPGiuseppe Plebani
Giuseppe Plebani
FFFranco Franchignoni
Franco Franchignoni

1 October 2014 in Disability and Health Journal
Verified
Journal Article
Closed access
EBElisabetta Bravini
Elisabetta Bravini
FFFranco Franchignoni
Franco Franchignoni
GFGiorgio Ferriero
Giorgio Ferriero
AGAndrea Giordano
Andrea Giordano
HBHadeel R. Bakhsh
Hadeel R. Bakhsh
SVStefano Vercelli
Stefano Vercelli

1 June 2013 in Manual Therapy
Verified
Journal Article
Closed access
SVStefano Vercelli
Stefano Vercelli
GFGiorgio Ferriero
Giorgio Ferriero
EBElisabetta Bravini
Elisabetta Bravini
FSFrancesco Sartorio
Francesco Sartorio

1 July 2014 in Annals of Saudi Medicine
Verified
Journal Article
Open access
HBHadeel R. Bakhsh
Hadeel R. Bakhsh
FFFranco Franchignoni
Franco Franchignoni
EBElisabetta Bravini
Elisabetta Bravini
GFGiorgio Ferriero
Giorgio Ferriero
AGAndrea Giordano
Andrea Giordano
CFCalogero Foti
Calogero Foti
Assessing patient satisfaction with orthosis (PSwO) is a key point for clinical practice to increase a patient's adherence to therapeutic programs and reduce orthotic-related costs. The Client Satisfaction with Device (CSD) module of the Orthotics and Prosthetics Users' Survey (OPUS) is one of the most widely-used questionnaires for assessing PSwO, but its validated version in the Arabic language is lacking. The objective of this study is to generate and psychometrically validate an Arabic version of the CSD (CSD-Ar). This is a cross-sectional study, conducted during February to June 2013 at 2 inpatient and outpatient rehabilitation departments in Riyadh, Saudi Arabia. Translation of CSD-Ar was carried out according to the guideline recommendations of Linacre. A convenience sample of 100 orthotic-user patients with various conditions (59% men, mean age 36 years) completed the CSD-Ar. Data were analyzed using exploratory factor analysis followed by Rasch analysis. Factor analysis confirmed the unidimensionality of the CSD-Ar. Rasch criteria for the functioning of rating scale categories were fulfilled. All items showed an adequate fit to the Rasch model. The person separation reliability was .75 and Cronbach alpha .83. There was a borderline local dependency between items 1 ("My device fits well") and 3 ("My device is comfortable throughout the day"). The internal construct validity of the CSD-Ar in Arab patients with various types of orthotics has been confirmed. This study provides a useful starting point for the use of this outcome measure in Arabic-speaking countries.